MARKET

CLSDQ

CLSDQ

Clearside
OTCPK
0.310
NaN%
Closed 09:30 06/09 EDT
OPEN
--
PREV CLOSE
0.310
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
17.10
52 WEEK LOW
0.150
MARKET CAP
1.62M
P/E (TTM)
-0.0613
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CLSDQ last week (0601-0605)?
Weekly Report · 1d ago
Weekly Report: what happened at CLSDQ last week (0525-0529)?
Weekly Report · 06/01 10:23
Weekly Report: what happened at CLSDQ last week (0518-0522)?
Weekly Report · 05/25 10:26
Weekly Report: what happened at CLSDQ last week (0511-0515)?
Weekly Report · 05/18 10:26
Weekly Report: what happened at CLSDQ last week (0504-0508)?
Weekly Report · 05/11 10:23
Weekly Report: what happened at CLSDQ last week (0427-0501)?
Weekly Report · 05/04 10:21
Weekly Report: what happened at CLSDQ last week (0420-0424)?
Weekly Report · 04/27 10:24
Weekly Report: what happened at CLSDQ last week (0413-0417)?
Weekly Report · 04/20 10:19
More
About CLSDQ
Clearside Biomedical, Inc. is a biopharmaceutical company focused on the delivery of therapies to the back of the eye through the suprachoroidal space (SCS). The Company's SCS injection platform, utilizing its patented SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases. The Company is developing its own pipeline of small molecule product candidates for administration via its SCS Microinjector. The Company's lead program, CLS-AX (axitinib injectable suspension), for the treatment of neovascular age-related macular degeneration (wet AMD). It developed and gained approval for its product, XIPERE (triamcinolone acetonide injectable suspension) for suprachoroidal use, which is available in the United States through a commercial partner.

Webull offers Clearside Biomedical, Inc stock information, including OTCPK: CLSDQ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLSDQ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLSDQ stock methods without spending real money on the virtual paper trading platform.